Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
M03BX09
CAS registry number (Chemical Abstracts Service)
0064840-90-0
Chemical Formula
C17-H25-N-O
Molecular Weight
259
Therapeutic Category
Muscle relaxant
Chemical Name
1-Propanone, 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-
Foreign Names
- Eperisonum (Latin)
- Eperison (German)
- Epérisone (French)
- Eperisona (Spanish)
Generic Names
- Eperisone Hydrochloride (OS: JAN)
- EMPP (IS)
- Eperisone Hydrochloride (PH: JP XV)
Brand Names
- Akitonal
Choseido Pharmaceutical, Japan - Atines
ASKA SeiyakuAsuka, Japan - Envoy
Kyorin Rimedio, Japan - Epel
Towa Yakuhin, Japan - Epenard
Taiyo Pharmaceutical, Japan - Eperinal
Tsuruhara Seiyaku, Japan - Eperisser
Nipro PharmaNipurofama, Japan - Epeso
Isei, Japan - Eprel
Orion, Bangladesh - Eprinoc
Sanbe, Indonesia - Estalex
Ifars, Indonesia - Evonton
Tatsumi Kagaku, Japan - Forelax
Guardian Pharmatama, Indonesia - Homerlight
Nisshin Seiyaku - Yamagata, Japan - Lional
Landson, Indonesia - Myobat
Interbat, Indonesia - Myoman
Metiska, Indonesia - Myonabase
Kotobuki Seiyaku, Japan - Myonal
Eisai, Bangladesh; Eisai, China; Eisai, Dominican Republic; Eisai, Guatemala; Eisai, Indonesia; Eisai, Japan; Eisai, Myanmar; Eisai, Malaysia; Eisai, Philippines; Eisai, Singapore; Eisai, El Salvador; Eisai, Thailand; Eisai, Vietnam - Myonep
Lapi Laboratories, Indonesia - Myonil
Square, Bangladesh - Myoperison
Kobayashi Kako, Japan - Myorelark
Kyowa Yakuhin, Japan - Myori
Tempo Scan Pacific, Indonesia - Permyo
Ferron, Indonesia - Rinpral
Nichi-Iko PharmaceuticalJMA, Japan - Rizonax
Novell, Indonesia - Sunbazon
Asahi Kasei, Japan - Tolmynal
Taisho Yakuhin, Japan - Zonal
Kalbe, Indonesia
International Drug Name Search
Glossary
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment